1. Christ W, et al: Specific toxicologic aspects of the quinolones. Rev Infec Dis10 (Suppl):141-146, 1988
2.
2. Product information. Noroxin R (Norfloxacin). West Point, PA: Merck Sharp and Dohme, 1989
3.
3. Product information. Cipro' (Ciprofloxacin). West Point, PA: Merck Sharp and Dohme, 1989
4.
4. Jawad ASM: Cystic fibrosis and drug induced arthropathy (letter). Br J Rheum28:179-180, 1989
5.
5. Alfaham M, Holt ME, Goodchild MC: Arthropathy in a patient with cystic fibrosis taking ciprofloxacin (letter). Br Med J295:699-699, 1987
6.
6. Pertuiset E, et al: Joint tolerance of pefloxacin and ofloxacin in children and teenagers with mucoviscidosis. Rev Rhumat Malad Osteo Articulaires56:735-740, 1989
7.
7. Wise R.Norfloxacin a review of pharmacology and tissue penetration. J Antimicrob Chemother13 (Suppl B):59-64, 1984
8.
8. Cover DL, Mueller BA: Ciprofloxacin penetration into human breast milk: a case report. DICP Ann Pharmacother24:703-704, 1990
9.
9. Giamarellou H, et al: Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med87 (Suppl 5A):49-51, 1989
